The present disclosure provides a novel process for the continuous extraction, purification and production of a flavan-3-ol extract from early harvested whole grape clusters. The final product from this process is particularly rich in monomeric and oligomeric flavan-3-ols and with an unusually high conversion of the final product into flavan-3-ol subunits under acid catalysis conditions. The oligomers and polymers in the final product are frequently referred to as proanthocyanidins in the field of polyphenol chemistry. The disclosure provides a novel process for the production of the final product via a continuous extraction process and with a final product having a unique composition.

The present invention relates to a chromatography system wherein the chromatography system comprises an eluting system and a capturing system consisting of at least two chromatography units operated alone or in series and a capturing process employing in-line buffer dilution in, which concentrated buffers are blended with water and provided to the chromatography units.

In accordance with one or more embodiments of the present disclosure, a process for treating a hydrocarbon feedstream having nitrogen-containing compounds and polynuclear aromatic compounds includes contacting the hydrocarbon feedstream with an adsorbent material; introducing the adsorbent-treated hydrocarbon feedstream to a hydrocracking reaction unit to produce a hydrocracked effluent stream; introducing a naphtha stream to a catalytic reforming unit to produce a reformate stream; introducing the reformate stream to an aromatic recovery complex to produce a light reformate stream, a BTX stream, and an aromatic bottoms stream; and introducing the aromatic bottoms stream to the used adsorbent to release at least a portion of the nitrogen-containing compounds and polynuclear compounds.

The present disclosure provides methods for the separation and quantification of empty and full viral capsids (e.g., AAV capsids) within a viral preparation, such as a viral pharmaceutical composition or drug product.

The present disclosure provides purification platforms comprising a depth filter step and/or a hydrophobic interaction chromatography (HIC) step and/or a MM-HIC/IEX chromatography step, and are useful for providing a method of reducing a hydrolytic enzyme activity rate of a composition obtained from said purification platforms. Also disclosed herein are methods of using the purification platforms described herein and compositions obtained therefrom, such as pharmaceutical compositions.

The invention provides processes of purifying a peptide including a GCC agonist sequence selected from the group consisting of SEQ ID NOs: 1-251 described herein. The processes include a solvent exchange step before a freeze-drying (lyophilization) step.

A method for the manufacture of highly purified .sup.68Ge material for radiopharmaceutical purposes. The invention particularly concerns the production of .sup.68Ge-API (API=Active Pharmaceutical Ingredient) solution complying with the Guidelines for good manufacturing practices (GMP). Starting material for the method of the present invention can be a .sup.68Ge stock solution of commercial or other origin as raw material. Such .sup.68Ge containing raw solutions are purified from potential metal and organic impurities originating from production processes. The radiochemical method disclosed is based on a twofold separation of .sup.68Ge from organic and metallic impurities with two different adsorbent materials. During the first separation phase .sup.68Ge is purified from both organic and metallic impurities by adsorption in germanium tetrachloride form, after which hydrolyzed .sup.68Ge is purified from remaining metallic impurities by cation exchange. The final .sup.68Ge-API-product e.g. fulfills the regulatory requirements for specifications of the GMP production of .sup.68Ge/.sup.68Ga generators.

A biological material extraction carrier includes a magnetic bead including a magnetic metal powder and a first coating layer that coats a particle surface of the magnetic metal powder and that is made of a first oxide material, and an oxide powder, in which a particle surface is made of a second oxide material, and an average particle diameter is smaller than that of the magnetic bead. Further, the average particle diameter of the magnetic bead is preferably 0.5 μm or more and 50 μm or less.

Provided is a method for producing a lithium-containing solution that prevents the dissolution of the whole lithium manganese oxide while maintaining the efficiency of an elution step. The method for producing a lithium-containing solution comprises performing an adsorption step of contacting a lithium adsorbent obtained from lithium manganese oxide with a low lithium-containing liquid for adsorption to give post-adsorption lithium manganese oxide, an elution step of contacting the post-adsorption lithium manganese oxide with an acid solution to give a lithium-containing solution with residual manganese, and a manganese oxidation step of oxidating manganese to give a lithium-containing solution with a suppressed manganese concentration, performed in this order. The acid solution is a 0.5 mol/L or more and 4.0 mol/L or less hydrochloric acid solution. According to the production method, in the elution step, the dissolution of the whole lithium manganese oxide can be suppressed while maintaining the efficiency of exchange reaction between cations including Li.sup.+ and H.sup.+. Thus, the repeated use of the lithium adsorbent becomes possible.

A chromatography device is provided comprising a filter housing having an inlet and an outlet and defining a fluid flow path between the inlet and the outlet; a porous filter arranged in the filter housing across the fluid flow path, the filter comprising first porous filter element; and a second porous filter element in contact with the first porous filter element, wherein the first porous filter element comprises at least one anionic exchange (AEX) layer, and the second porous filter element comprises at least one hydrophobic interaction (HIC) layer. A method of purifying nucleic acid using the device is also provided.